Search research articles
Contact Us
Filters
Showing results (391-400 of 412) with videos related to
Page
of 42
Sort By:
The Lancet. Oncology
|
February 28, 2020
Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials
David S Hong, Steven G DuBois, Shivaani Kummar, et al.
Oncoimmunology
|
January 3, 2024
A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies
Chia-Chi Lin, Elena Garralda, Patrick Schöffski, et al.
Cancer Discovery
|
July 8, 2024
Mechanisms of Response and Tolerance to Active RAS Inhibition in KRAS-Mutant Non-Small Cell Lung Cancer
Haniel A Araujo, Ximo Pechuan-Jorge, Teng Zhou, et al.
Molecular Therapy. Methods & Clinical Development
|
June 14, 2024
Identifying MAGE-A4-positive tumors for TCR T cell therapies in HLA-A∗02-eligible patients
Tianjiao Wang, Jean-Marc Navenot, Stavros Rafail, et al.
Nature Medicine
|
May 28, 2025
Molecular determinants of sotorasib clinical efficacy in KRAS<sup>G12C</sup>-mutated non-small-cell lung cancer
Ferdinandos Skoulidis, Bob T Li, Adrianus Johannes de Langen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 13, 2020
Intratumoral Injection of <i>Clostridium novyi</i>-NT Spores in Patients with Treatment-refractory Advanced Solid Tumors
Filip Janku, Halle Huihong Zhang, Abdulmohammad Pezeshki, et al.
Journal for Immunotherapy of Cancer
|
February 26, 2022
Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) ± anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies
Patrick Schöffski, Daniel S W Tan, Miguel Martín, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 25, 2017
Development and Validation of an Ultradeep Next-Generation Sequencing Assay for Testing of Plasma Cell-Free DNA from Patients with Advanced Cancer
Filip Janku, Shile Zhang, Jill Waters, et al.
Neuro-Oncology
|
December 1, 2021
Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors
François Doz, Cornelis M van Tilburg, Birgit Geoerger, et al.
Cancer Immunology Research
|
October 30, 2019
Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation-Related Abscopal Responses
James W Welsh, Chad Tang, Patricia de Groot, et al.
Page
of 42
Search research articles
Search
Showing results (391-400 of 412) with videos related to
Sort By:
Page
of 42
The Lancet. Oncology
|
February 28, 2020
Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials
David S Hong, Steven G DuBois, Shivaani Kummar, et al.
Oncoimmunology
|
January 3, 2024
A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies
Chia-Chi Lin, Elena Garralda, Patrick Schöffski, et al.
Cancer Discovery
|
July 8, 2024
Mechanisms of Response and Tolerance to Active RAS Inhibition in KRAS-Mutant Non-Small Cell Lung Cancer
Haniel A Araujo, Ximo Pechuan-Jorge, Teng Zhou, et al.
Molecular Therapy. Methods & Clinical Development
|
June 14, 2024
Identifying MAGE-A4-positive tumors for TCR T cell therapies in HLA-A∗02-eligible patients
Tianjiao Wang, Jean-Marc Navenot, Stavros Rafail, et al.
Nature Medicine
|
May 28, 2025
Molecular determinants of sotorasib clinical efficacy in KRAS<sup>G12C</sup>-mutated non-small-cell lung cancer
Ferdinandos Skoulidis, Bob T Li, Adrianus Johannes de Langen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 13, 2020
Intratumoral Injection of <i>Clostridium novyi</i>-NT Spores in Patients with Treatment-refractory Advanced Solid Tumors
Filip Janku, Halle Huihong Zhang, Abdulmohammad Pezeshki, et al.
Journal for Immunotherapy of Cancer
|
February 26, 2022
Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) ± anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies
Patrick Schöffski, Daniel S W Tan, Miguel Martín, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 25, 2017
Development and Validation of an Ultradeep Next-Generation Sequencing Assay for Testing of Plasma Cell-Free DNA from Patients with Advanced Cancer
Filip Janku, Shile Zhang, Jill Waters, et al.
Neuro-Oncology
|
December 1, 2021
Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors
François Doz, Cornelis M van Tilburg, Birgit Geoerger, et al.
Cancer Immunology Research
|
October 30, 2019
Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation-Related Abscopal Responses
James W Welsh, Chad Tang, Patricia de Groot, et al.
Page
of 42